Universidad Peruana Cayetano Heredia

Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort

Mostrar el registro sencillo del ítem

dc.contributor.author Carriquiry, Gabriela
dc.contributor.author Giganti, Mark J.
dc.contributor.author Castilho, Jessica L.
dc.contributor.author Jayathilake, Karu
dc.contributor.author Cahn, Pedro
dc.contributor.author Grinsztejn, Beatriz
dc.contributor.author Cortes, Claudia
dc.contributor.author Pape, Jean W.
dc.contributor.author Padgett, Denis
dc.contributor.author Sierra‐Madero, Juan
dc.contributor.author McGowan, Catherine C.
dc.contributor.author Shepherd, Bryan E.
dc.contributor.author Gotuzzo Herencia, José Eduardo
dc.date.accessioned 2018-06-18T15:26:49Z
dc.date.available 2018-06-18T15:26:49Z
dc.date.issued 2018
dc.identifier.uri https://hdl.handle.net/20.500.12866/3667
dc.description.abstract Introduction: The “greying” of the HIV epidemic necessitates a better understanding of the healthcare needs of older HIV-positive adults. As these individuals age, it is unclear whether comorbidities and their associated therapies or the ageing process itself alter the response to antiretroviral therapy (ART). In this study, HIV treatment outcomes and corresponding risk factors were compared between older ART initiators and those who were younger using data from the Caribbean, Central and South America Network for HIV Epidemiology (CCASAnet). Methods HIV-positive adults (≥18 years) initiating ART at nine sites in Argentina, Brazil, Chile, Haiti, Honduras, Mexico and Peru were included. Patients were classified as older (≥50 years) or younger (<50 years) based on age at ART initiation. ART effectiveness was measured using three outcomes: death, virologic failure and ART treatment modification. Cox regression models for each outcome compared risk between older and younger patients, adjusting for other covariates. Results Among 26,311 patients initiating ART between 1996 and 2016, 3389 (13%) were ≥50 years. The majority of patients in both ≥50 and <50 age groups received a non-nucleoside reverse transcriptase inhibitor-based regimen (89% vs. 87%), did not have AIDS at baseline (63% vs. 62%), and were male (59% vs. 58%). Older patients had a higher risk of death (adjusted hazard ratio (aHR) 1.64; 95% confidence intervals (CI): 1.48 to 1.83) and a lower risk of virologic failure (aHR: 0.73; 95% CI: 0.63 to 0.84). There was no difference in risk of ART modification (aHR: 1.00; 95% CI: 0.94 to 1.06). Risk factors for death, virologic failure and treatment modification were similar for each group. Conclusions Older age at ART initiation was associated with increased mortality and decreased risk of virologic failure in our cohort of more than 26,000 ART initiators in Latin America and the Caribbean. To the best of our knowledge this is the first study from the region to evaluate ART outcomes in this growing and important population. Given the complexity of issues related to ageing with HIV, a greater understanding is needed in order to properly respond to this shifting epidemic. en_US
dc.language.iso eng
dc.publisher Wiley
dc.relation.ispartofseries Journal of the International AIDS Society
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject HIV en_US
dc.subject Ageing en_US
dc.subject Over 50 en_US
dc.subject Latin America en_US
dc.subject Caribbean en_US
dc.subject ART outcomes en_US
dc.subject Virologic failure en_US
dc.title Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1002/jia2.25088
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.03.08
dc.relation.issn 1758-2652


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas